Clopidogrel

Clopidogrel is a prodrug P2Y12 ADP receptor antagonist that irreversibly inhibits platelet aggregation. It is one of the most widely prescribed cardiovascular drugs globally, used for prevention of atherosclerotic events including heart attack and stroke in patients with ACS, peripheral arterial disease, or recent stroke. Mediocon Inc supplies pharmaceutical-grade Clopidogrel meeting IP/BP/EP/USP standards.

Key Features

• Irreversible P2Y12 ADP receptor antagonist prodrug
• IP/BP/EP/USP compliant, Assay 99.0% Min.
• Prevents MI, stroke, and vascular death
• Suitable for oral tablet formulations

Applications

• Acute coronary syndrome treatment
• Stroke prevention tablets
• Peripheral arterial disease therapy
• Dual antiplatelet therapy with aspirin

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings